![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 7034 |
FusionGeneSummary for CHD9_DLC1 |
![]() |
Fusion gene information | Fusion gene name: CHD9_DLC1 | Fusion gene ID: 7034 | Hgene | Tgene | Gene symbol | CHD9 | DLC1 | Gene ID | 80205 | 10395 |
Gene name | chromodomain helicase DNA binding protein 9 | DLC1 Rho GTPase activating protein | |
Synonyms | AD013|CHD-9|CReMM|KISH2|PRIC320 | ARHGAP7|HP|STARD12|p122-RhoGAP | |
Cytomap | 16q12.2 | 8p22 | |
Type of gene | protein-coding | protein-coding | |
Description | chromodomain-helicase-DNA-binding protein 9ATP-dependent helicase CHD9PPAR-alpha-interacting complex protein 320 kDaPPAR{gamma}-interacting cofactor 320 kDachromatin remodeling factor CHROM1chromatin-related mesenchymal modulatorciprofibrate bound p | rho GTPase-activating protein 7Rho-GTPase-activating protein 7START domain-containing protein 12StAR-related lipid transfer (START) domain containing 12deleted in liver cancer 1 proteindeleted in liver cancer 1 variant 2deleted in liver cancer varia | |
Modification date | 20180519 | 20180519 | |
UniProtAcc | Q3L8U1 | Q96QB1 | |
Ensembl transtripts involved in fusion gene | ENST00000447540, ENST00000566029, ENST00000564845, ENST00000398510, ENST00000564582, | ENST00000276297, ENST00000358919, ENST00000512044, ENST00000316609, ENST00000511869, ENST00000510318, ENST00000520226, | |
Fusion gene scores | * DoF score | 8 X 5 X 5=200 | 8 X 7 X 4=224 |
# samples | 8 | 8 | |
** MAII score | log2(8/200*10)=-1.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/224*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CHD9 [Title/Abstract] AND DLC1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | DLC1 | GO:0006915 | apoptotic process | 17292327 |
Tgene | DLC1 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 17888903 |
Tgene | DLC1 | GO:0008285 | negative regulation of cell proliferation | 12545165|17932950 |
Tgene | DLC1 | GO:0030336 | negative regulation of cell migration | 17932950|19158340 |
Tgene | DLC1 | GO:0035307 | positive regulation of protein dephosphorylation | 17292327 |
Tgene | DLC1 | GO:0051497 | negative regulation of stress fiber assembly | 17932950 |
Tgene | DLC1 | GO:0051895 | negative regulation of focal adhesion assembly | 19158340 |
Tgene | DLC1 | GO:1900119 | positive regulation of execution phase of apoptosis | 17888903 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BRCA | TCGA-AR-A1AN-01A | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000447540 | ENST00000276297 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000447540 | ENST00000358919 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000447540 | ENST00000512044 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000447540 | ENST00000316609 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000447540 | ENST00000511869 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000447540 | ENST00000510318 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000447540 | ENST00000520226 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
Frame-shift | ENST00000566029 | ENST00000276297 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000566029 | ENST00000358919 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000566029 | ENST00000512044 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000566029 | ENST00000316609 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000566029 | ENST00000511869 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000566029 | ENST00000510318 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000566029 | ENST00000520226 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
Frame-shift | ENST00000564845 | ENST00000276297 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000564845 | ENST00000358919 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000564845 | ENST00000512044 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000564845 | ENST00000316609 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000564845 | ENST00000511869 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000564845 | ENST00000510318 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000564845 | ENST00000520226 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
Frame-shift | ENST00000398510 | ENST00000276297 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000398510 | ENST00000358919 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000398510 | ENST00000512044 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000398510 | ENST00000316609 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000398510 | ENST00000511869 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000398510 | ENST00000510318 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
5CDS-intron | ENST00000398510 | ENST00000520226 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
intron-3CDS | ENST00000564582 | ENST00000276297 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
intron-intron | ENST00000564582 | ENST00000358919 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
intron-intron | ENST00000564582 | ENST00000512044 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
intron-intron | ENST00000564582 | ENST00000316609 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
intron-intron | ENST00000564582 | ENST00000511869 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
intron-intron | ENST00000564582 | ENST00000510318 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
intron-intron | ENST00000564582 | ENST00000520226 | CHD9 | chr16 | 53308214 | + | DLC1 | chr8 | 13162811 | - |
Top |
FusionProtFeatures for CHD9_DLC1 |
![]() |
Hgene | Tgene |
CHD9 | DLC1 |
Acts as a transcriptional coactivator for PPARA andpossibly other nuclear receptors. Proposed to be a ATP-dependentchromatin remodeling protein. Has DNA-dependent ATPase activityand binds to A/T-rich DNA. Associates with A/T-rich regulatoryregions in promoters of genes that participate in thedifferentiation of progenitors during osteogenesis (Bysimilarity). {ECO:0000250, ECO:0000269|PubMed:16095617,ECO:0000269|PubMed:16554032}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CHD9_DLC1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CHD9_DLC1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CHD9 | ESR1, NR1I3, PPARA, RXRA, SOX2, FGG, PRICKLE3, MYC, PRKCD, EDEM1, VPS26B, C10orf2, C11orf30, PHF12, EPB41L5, PIP4K2A, NKAP, MDK, CAMKV, BRCA1 | DLC1 | WWC1, S100A10, TENC1, CAV1, CUL1, CUL2, CUL3, CUL4A, DDB1, FBXW5, AKT1, RPS6KA1, WWC2, WWC3, FBXW7, LACC1, FEM1B, C17orf75, PTEN |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CHD9_DLC1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CHD9_DLC1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | DLC1 | C0038356 | Stomach Neoplasms | 1 | CTD_human;HPO |
Tgene | DLC1 | C0919267 | ovarian neoplasm | 1 | CTD_human |